Study to Assess Efficacy and Safety of M72/AS01E-4 Mycobacterium Tuberculosis (Mtb) Vaccine in Adolescents and Adults
Clinical trial NCT06062238 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06062238
- Sponsor
- Gates Medical Research Institute
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-03-05
- Primary completion
- 2028-04-01
- Enrollment
- 20080
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.